About
Small Molecules for Lipid-related Diseases
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (37)
View allTotal Trials
37
As Lead Sponsor
21
As Collaborator
16
Total Enrollment
11,624
By Phase
PHASE2: 19PHASE1: 6NA: 3PHASE3: 3PHASE1/PHASE2: 4PHASE2/PHASE3: 1PHASE4: 1
By Status
COMPLETED: 33WITHDRAWN: 2TERMINATED: 2
Clinical Trials Pipeline34 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT04627831Lead Sponsor
Comparison of Captisol-Enabled™ Iohexol and Omnipaque™ in Patients With Impaired Renal Function Undergoing Coronary Angiography
PHASE2Withdrawn
Started: Jan 31, 2022 · Completed: Apr 30, 2023
NCT04629976Collaborator
Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B
PHASE1Completed
21 participants
Started: Jan 12, 2021 · Completed: Dec 28, 2022
NCT04309526Collaborator
Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy Subjects
PHASE1Completed
48 participants
Started: Mar 18, 2020 · Completed: Oct 13, 2020
NCT03869983Collaborator
Relative Bioavailability of CE-Iohexol (Captisol-enabled™ Iohexol) Injection and Omnipaque™ Injection
NACompleted
24 participants
Started: Apr 12, 2019 · Completed: Jun 15, 2019
NCT02851849Lead Sponsor
A Study of LGD-6972 in Patients With Type 2 Diabetes Mellitus
PHASE2Completed
148 participants
Started: Sep 30, 2016 · Completed: Jun 30, 2017
Locations (1)
Headquarters
Umeå, Sweden
Map
Loading map...